| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GO_term | pVal | numberOfMatches | fractionOfDB_Observed | Cond1med_int | Cond2med_int | qVal | dif | ||||||||||||||||||
2 | 1 | symporter activity | 2.76E-09 | 3 | 0.0625 | 0.07047265514 | 0.3145752226 | 8.14E-09 | -0.2441025675 | |||||||||||||||||
3 | 2 | primary cilium | 1.34E-09 | 5 | 0.119047619 | 0.002541514118 | 0.4328654878 | 4.04E-09 | -0.4303239737 | |||||||||||||||||
4 | 3 | core promoter binding | 9.06E-15 | 7 | 0.1346153846 | -0.002641969967 | 0.2971846914 | 3.97E-14 | -0.2998266614 | |||||||||||||||||
5 | 4 | placenta development | 3.49E-07 | 5 | 0.08196721311 | -0.1133003466 | -0.4332414929 | 8.48E-07 | 0.3199411463 | |||||||||||||||||
6 | 5 | extrinsic to internal side of plasma membrane | 7.00E-17 | 8 | 0.16 | 0.1004404722 | -0.2319295987 | 3.39E-16 | 0.3323700709 | |||||||||||||||||
7 | 6 | positive regulation of neuron differentiation | 5.39E-09 | 9 | 0.06 | 0.03965032241 | -0.2021776655 | 1.57E-08 | 0.2418279879 | |||||||||||||||||
8 | 7 | MAPK cascade | 2.62E-11 | 12 | 0.08450704225 | 0.1048006868 | -0.1793793639 | 8.99E-11 | 0.2841800506 | |||||||||||||||||
9 | 8 | activation of MAPK activity | 7.62E-06 | 13 | 0.104 | 0.04731673067 | -0.2264043752 | 1.65E-05 | 0.2737211059 | |||||||||||||||||
10 | 9 | positive regulation of epithelial cell proliferation | 5.10E-08 | 6 | 0.07142857143 | 0.3063170325 | -0.1581584781 | 1.34E-07 | 0.4644755106 | |||||||||||||||||
11 | 10 | Rho GTPase activator activity | 1.33E-45 | 7 | 0.2333333333 | -0.04587860627 | -1.108465773 | 1.87E-44 | 1.062587167 | |||||||||||||||||
12 | 11 | cytoskeleton organization | 2.16E-17 | 20 | 0.1515151515 | 0.08524111871 | -0.3638122483 | 1.07E-16 | 0.449053367 | |||||||||||||||||
13 | 12 | positive regulation of Rho GTPase activity | 6.73E-34 | 7 | 0.1320754717 | 0.001907167788 | -1.051208154 | 6.72E-33 | 1.053115322 | |||||||||||||||||
14 | 13 | phagocytic vesicle membrane | 2.28E-16 | 13 | 0.1111111111 | -0.06790532222 | 0.2775439004 | 1.07E-15 | -0.3454492226 | |||||||||||||||||
15 | 14 | intermediate filament | 1.85E-09 | 7 | 0.04458598726 | 0.332317156 | 0.6052894759 | 5.55E-09 | -0.2729723199 | |||||||||||||||||
16 | 15 | chloride transport | 7.93E-09 | 5 | 0.07352941176 | 0.01650175773 | -0.3134190192 | 2.26E-08 | 0.3299207769 | |||||||||||||||||
17 | 16 | transmembrane transporter activity | 4.13E-63 | 12 | 0.1846153846 | 0.09423956877 | 0.4025368297 | 8.79E-62 | -0.308297261 | |||||||||||||||||
18 | 17 | odontogenesis of dentin-containing tooth | 4.94E-06 | 7 | 0.05882352941 | 0.04410889077 | 0.2579804115 | 1.08E-05 | -0.2138715207 | |||||||||||||||||
19 | 18 | endonuclease activity | 1.32E-16 | 10 | 0.1785714286 | 0.06159712597 | -0.229155733 | 6.26E-16 | 0.2907528589 | |||||||||||||||||
20 | 19 | peroxidase activity | 1.18E-17 | 8 | 0.2 | 0.2018304087 | -0.06306964172 | 6.02E-17 | 0.2649000504 | |||||||||||||||||
21 | 20 | hydrogen peroxide catabolic process | 4.21E-25 | 9 | 0.45 | 0.184291544 | -0.1839589323 | 3.20E-24 | 0.3682504763 | |||||||||||||||||
22 | 21 | acid-amino acid ligase activity | 2.91E-36 | 7 | 0.056 | 0.1300777285 | -0.5181059089 | 3.14E-35 | 0.6481836375 | |||||||||||||||||
23 | 22 | triglyceride biosynthetic process | 6.55E-35 | 6 | 0.1132075472 | 0.2812587097 | -0.2852960106 | 6.66E-34 | 0.5665547203 | |||||||||||||||||
24 | 23 | long-chain fatty-acyl-CoA biosynthetic process | 6.55E-35 | 6 | 0.3529411765 | 0.2812587097 | -0.2852960106 | 6.66E-34 | 0.5665547203 | |||||||||||||||||
25 | 24 | cellular lipid metabolic process | 2.27E-12 | 34 | 0.2048192771 | 0.1011912136 | 0.2368283553 | 8.51E-12 | -0.1356371417 | |||||||||||||||||
26 | 25 | skeletal system development | 1.87E-20 | 14 | 0.09150326797 | 0.3169446135 | -0.04474522203 | 1.09E-19 | 0.3616898355 | |||||||||||||||||
27 | 26 | extracellular matrix disassembly | 4.74E-05 | 22 | 0.1929824561 | -0.01398448011 | 0.157562313 | 9.46E-05 | -0.1715467932 | |||||||||||||||||
28 | 27 | adipose tissue development | 3.63E-05 | 6 | 0.1621621622 | 0.0206334878 | 0.1626637501 | 7.34E-05 | -0.1420302623 | |||||||||||||||||
29 | 28 | negative regulation of cell growth | 2.60E-05 | 16 | 0.09937888199 | 0.08116405751 | -0.06356952832 | 5.32E-05 | 0.1447335858 | |||||||||||||||||
30 | 29 | axonogenesis | 1.41E-10 | 17 | 0.136 | 0.0515469222 | -0.08934166658 | 4.57E-10 | 0.1408885888 | |||||||||||||||||
31 | 30 | negative regulation of microtubule polymerization | 2.02E-29 | 6 | 0.4285714286 | 0.04027544569 | -0.2787416337 | 1.78E-28 | 0.3190170794 | |||||||||||||||||
32 | 31 | positive regulation of cellular component movement | 3.26E-77 | 4 | 0.2666666667 | 0.04026530739 | -0.4593398901 | 9.88E-76 | 0.4996051975 | |||||||||||||||||
33 | 32 | glutathione metabolic process | 5.29E-09 | 10 | 0.1449275362 | -0.02572130498 | -0.326463238 | 1.54E-08 | 0.300741933 | |||||||||||||||||
34 | 33 | pyridoxal phosphate binding | 1.63E-06 | 11 | 0.06790123457 | 0.106506474 | 0.1869780287 | 3.77E-06 | -0.08047155468 | |||||||||||||||||
35 | 34 | ubiquitin-ubiquitin ligase activity | 2.77E-05 | 4 | 0.3333333333 | 0.005381222525 | 0.2534489224 | 5.65E-05 | -0.2480676999 | |||||||||||||||||
36 | 35 | integral to endoplasmic reticulum membrane | 2.34E-05 | 10 | 0.1063829787 | -0.003601256056 | 0.2176404646 | 4.80E-05 | -0.2212417206 | |||||||||||||||||
37 | 36 | response to oxidative stress | 5.26E-10 | 20 | 0.1136363636 | 0.1467269626 | -0.06229925148 | 1.63E-09 | 0.2090262141 | |||||||||||||||||
38 | 37 | learning or memory | 2.92E-24 | 5 | 0.06944444444 | -0.03502239627 | -0.5563321637 | 2.16E-23 | 0.5213097675 | |||||||||||||||||
39 | 38 | ATP-dependent protein binding | 3.55E-06 | 3 | 0.2727272727 | 0.008226697851 | -0.1710451605 | 7.92E-06 | 0.1792718583 | |||||||||||||||||
40 | 39 | negative regulation of sequence-specific DNA binding transcription factor activity | 3.44E-16 | 8 | 0.126984127 | 0.009290446189 | -0.2079284236 | 1.59E-15 | 0.2172188698 | |||||||||||||||||
41 | 40 | negative regulation of T cell receptor signaling pathway | 1.93E-06 | 4 | 0.1904761905 | 0.2498244185 | -0.164093146 | 4.44E-06 | 0.4139175644 | |||||||||||||||||
42 | 41 | cytoskeletal protein binding | 2.09E-07 | 15 | 0.1485148515 | -0.03322414879 | -0.3649991141 | 5.22E-07 | 0.3317749653 | |||||||||||||||||
43 | 42 | extrinsic to membrane | 2.92E-13 | 13 | 0.1911764706 | -0.01559855988 | -0.2921780286 | 1.18E-12 | 0.2765794688 | |||||||||||||||||
44 | 43 | double-stranded RNA binding | 6.74E-12 | 24 | 0.3 | 0.01245191351 | 0.0007786421634 | 2.43E-11 | 0.01167327135 | |||||||||||||||||
45 | 44 | single-stranded RNA binding | 4.12E-15 | 5 | 0.119047619 | 0.003108097396 | 0.263208006 | 1.83E-14 | -0.2600999087 | |||||||||||||||||
46 | 45 | helicase activity | 7.06E-11 | 15 | 0.1094890511 | 0.0705234112 | -0.3054921824 | 2.32E-10 | 0.3760155936 | |||||||||||||||||
47 | 46 | response to virus | 1.17E-82 | 31 | 0.2039473684 | 0.04439139155 | -0.2977082734 | 4.11E-81 | 0.3420996649 | |||||||||||||||||
48 | 47 | actin filament organization | 2.04E-07 | 8 | 0.08988764045 | -0.1307890232 | -0.8891880493 | 5.13E-07 | 0.7583990261 | |||||||||||||||||
49 | 48 | multicellular organism growth | 1.18E-11 | 6 | 0.04615384615 | 0.1847467192 | 0.6057466032 | 4.19E-11 | -0.420999884 | |||||||||||||||||
50 | 49 | cilium | 1.04E-14 | 23 | 0.1493506494 | 0.1023556326 | -0.2633336585 | 4.49E-14 | 0.3656892911 | |||||||||||||||||
51 | 50 | aspartic-type endopeptidase activity | 2.04E-08 | 4 | 0.0487804878 | 0.04743238965 | 0.3874735909 | 5.62E-08 | -0.3400412012 | |||||||||||||||||
52 | 51 | intermediate filament cytoskeleton | 3.32E-05 | 13 | 0.1238095238 | 0.06868280148 | 0.219902642 | 6.73E-05 | -0.1512198405 | |||||||||||||||||
53 | 52 | glucose homeostasis | 2.25E-77 | 6 | 0.04511278195 | 0.1080313076 | -0.7182766147 | 6.94E-76 | 0.8263079222 | |||||||||||||||||
54 | 53 | anion transport | 1.84E-08 | 3 | 0.07142857143 | -0.02805957312 | 0.1523125069 | 5.09E-08 | -0.18037208 | |||||||||||||||||
55 | 54 | voltage-gated anion channel activity | 1.84E-08 | 3 | 0.2 | -0.02805957312 | 0.1523125069 | 5.09E-08 | -0.18037208 | |||||||||||||||||
56 | 55 | PML body | 3.61E-14 | 13 | 0.1214953271 | 0.127551236 | -0.1615424995 | 1.51E-13 | 0.2890937356 | |||||||||||||||||
57 | 56 | apoptotic signaling pathway | 2.39E-28 | 19 | 0.1557377049 | 0.1409041259 | -0.4552442122 | 2.04E-27 | 0.596148338 | |||||||||||||||||
58 | 57 | positive regulation of apoptotic signaling pathway | 2.51E-14 | 4 | 0.07843137255 | 0.1244843236 | -0.2835925972 | 1.06E-13 | 0.4080769208 | |||||||||||||||||
59 | 58 | protein export from nucleus | 3.48E-64 | 14 | 0.3111111111 | 0.08092305837 | -0.233635255 | 7.50E-63 | 0.3145583134 | |||||||||||||||||
60 | 59 | embryo implantation | 2.87E-06 | 4 | 0.04347826087 | 0.01007749029 | -0.1593401386 | 6.49E-06 | 0.1694176289 | |||||||||||||||||
61 | 60 | ATP-dependent DNA helicase activity | 3.91E-14 | 14 | 0.2692307692 | -0.005242287661 | 0.1366614492 | 1.63E-13 | -0.1419037368 | |||||||||||||||||
62 | 61 | DNA duplex unwinding | 3.27E-07 | 18 | 0.2168674699 | 0.02989876743 | 0.1222352833 | 7.98E-07 | -0.09233651587 | |||||||||||||||||
63 | 62 | cellular protein modification process | 3.25E-19 | 20 | 0.127388535 | 0.07801124408 | -0.09534618601 | 1.80E-18 | 0.1733574301 | |||||||||||||||||
64 | 63 | antigen processing and presentation | 2.30E-20 | 7 | 0.1129032258 | 0.002944391031 | 0.4294723988 | 1.33E-19 | -0.4265280078 | |||||||||||||||||
65 | 64 | proteolysis involved in cellular protein catabolic process | 8.16E-06 | 5 | 0.119047619 | -0.1261733993 | 0.06209951563 | 1.76E-05 | -0.1882729149 | |||||||||||||||||
66 | 65 | antigen processing and presentation of peptide antigen via MHC class I | 3.02E-08 | 57 | 0.3202247191 | -0.02864646055 | 0.03287299412 | 8.12E-08 | -0.06151945467 | |||||||||||||||||
67 | 66 | peptide antigen binding | 2.20E-08 | 5 | 0.04201680672 | -0.0957968045 | 0.198320928 | 5.99E-08 | -0.2941177325 | |||||||||||||||||
68 | 67 | protein peptidyl-prolyl isomerization | 1.67E-20 | 16 | 0.1720430108 | 0.008189899896 | -0.2223826689 | 9.90E-20 | 0.2305725688 | |||||||||||||||||
69 | 68 | peptidyl-prolyl cis-trans isomerase activity | 1.67E-20 | 16 | 0.1720430108 | 0.008189899896 | -0.2223826689 | 9.90E-20 | 0.2305725688 | |||||||||||||||||
70 | 69 | nucleoside diphosphate kinase activity | 3.61E-13 | 5 | 0.1111111111 | 0.2514156167 | -0.2526505088 | 1.44E-12 | 0.5040661255 | |||||||||||||||||
71 | 70 | nucleoside diphosphate phosphorylation | 3.61E-13 | 5 | 0.1136363636 | 0.2514156167 | -0.2526505088 | 1.44E-12 | 0.5040661255 | |||||||||||||||||
72 | 71 | GTP biosynthetic process | 3.52E-14 | 3 | 0.08333333333 | 0.2784596315 | -0.2800510407 | 1.47E-13 | 0.5585106723 | |||||||||||||||||
73 | 72 | UTP biosynthetic process | 6.81E-11 | 4 | 0.1081081081 | 0.1665599109 | -0.2016691749 | 2.25E-10 | 0.3682290859 | |||||||||||||||||
74 | 73 | CTP biosynthetic process | 1.41E-12 | 4 | 0.1081081081 | 0.1841374265 | -0.2016691749 | 5.42E-12 | 0.3858066015 | |||||||||||||||||
75 | 74 | tRNA binding | 2.68E-07 | 15 | 0.3 | -0.002071780695 | -0.1247327626 | 6.63E-07 | 0.1226609819 | |||||||||||||||||
76 | 75 | endosome to lysosome transport | 6.22E-12 | 5 | 0.1470588235 | 0.1312080584 | 0.4980739237 | 2.25E-11 | -0.3668658653 | |||||||||||||||||
77 | 76 | skeletal muscle cell differentiation | 2.30E-06 | 4 | 0.0625 | 0.1281900192 | 0.415302182 | 5.21E-06 | -0.2871121628 | |||||||||||||||||
78 | 77 | cellular response to organic cyclic compound | 2.24E-08 | 5 | 0.07462686567 | -0.07542031048 | -0.3550675727 | 6.08E-08 | 0.2796472622 | |||||||||||||||||
79 | 78 | spindle assembly | 1.88E-31 | 4 | 0.05479452055 | 0.100599886 | -0.976319949 | 1.72E-30 | 1.076919835 | |||||||||||||||||
80 | 79 | regulation of heart rate by cardiac conduction | 6.04E-40 | 4 | 0.1666666667 | 0.3251947187 | -0.6161457271 | 7.21E-39 | 0.9413404457 | |||||||||||||||||
81 | 80 | negative regulation of retinoic acid receptor signaling pathway | 5.52E-10 | 3 | 0.0652173913 | -0.2428196643 | 0.1134367299 | 1.71E-09 | -0.3562563942 | |||||||||||||||||
82 | 81 | response to antibiotic | 2.32E-05 | 3 | 0.0612244898 | 0.03369581046 | 0.1976487316 | 4.77E-05 | -0.1639529212 | |||||||||||||||||
83 | 82 | hippo signaling cascade | 2.57E-64 | 6 | 0.1666666667 | 0.2426122561 | -0.5479305202 | 5.70E-63 | 0.7905427763 | |||||||||||||||||
84 | 83 | retina homeostasis | 2.21E-20 | 9 | 0.225 | 0.04743231812 | -0.2762051335 | 1.28E-19 | 0.3236374516 | |||||||||||||||||
85 | 84 | cell cortex | 1.90E-12 | 26 | 0.1436464088 | 0.1600424138 | -0.06612666572 | 7.17E-12 | 0.2261690795 | |||||||||||||||||
86 | 85 | blood microparticle | 4.94E-52 | 22 | 0.1358024691 | 0.02365284096 | -0.3316615824 | 8.11E-51 | 0.3553144234 | |||||||||||||||||
87 | 86 | lipid particle organization | 1.40E-71 | 4 | 0.3333333333 | 0.2427717848 | -0.8937655726 | 3.77E-70 | 1.136537357 | |||||||||||||||||
88 | 87 | viral infectious cycle | 0 | 89 | 0.7542372881 | 0.07554591935 | -0.5256822148 | 0 | 0.6012281342 | |||||||||||||||||
89 | 88 | membrane organization | 1.16E-51 | 58 | 0.3945578231 | 0.07561897234 | -0.1967793636 | 1.88E-50 | 0.2723983359 | |||||||||||||||||
90 | 89 | ruffle | 1.86E-62 | 32 | 0.2269503546 | 0.08467772368 | -0.2426615806 | 3.90E-61 | 0.3273393043 | |||||||||||||||||
91 | 90 | neuron differentiation | 1.09E-05 | 9 | 0.09375 | 0.150510213 | 0.05646583963 | 2.30E-05 | 0.09404437339 | |||||||||||||||||
92 | 91 | nucleosome | 1.45E-68 | 18 | 0.2168674699 | 0.02721348794 | 0.3487703817 | 3.64E-67 | -0.3215568937 | |||||||||||||||||
93 | 92 | nucleosome assembly | 5.01E-45 | 33 | 0.182320442 | 0.02064264067 | 0.2396112869 | 6.75E-44 | -0.2189686462 | |||||||||||||||||
94 | 93 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 7.76E-24 | 20 | 0.3636363636 | 0.03832083062 | -0.2884633557 | 5.66E-23 | 0.3267841864 | |||||||||||||||||
95 | 94 | nuclear-transcribed mRNA poly(A) tail shortening | 2.24E-35 | 9 | 0.3 | 0.04005845078 | -0.3240194274 | 2.35E-34 | 0.3640778782 | |||||||||||||||||
96 | 95 | regulation of translation | 6.57E-53 | 19 | 0.2567567568 | 0.08698211415 | -0.3150673875 | 1.11E-51 | 0.4020495016 | |||||||||||||||||
97 | 96 | estrogen receptor binding | 1.15E-14 | 8 | 0.275862069 | 0.07756036063 | 0.3261367733 | 4.96E-14 | -0.2485764127 | |||||||||||||||||
98 | 97 | gene silencing by RNA | 2.66E-10 | 9 | 0.2727272727 | 0.1103614022 | -0.2670916973 | 8.35E-10 | 0.3774530994 | |||||||||||||||||
99 | 98 | negative regulation of intracellular estrogen receptor signaling pathway | 3.15E-20 | 4 | 0.3333333333 | 0.152009403 | 0.5859748152 | 1.81E-19 | -0.4339654122 | |||||||||||||||||
100 | 99 | negative regulation of catalytic activity | 1.78E-14 | 19 | 0.1397058824 | 0.03875596528 | -0.1225254283 | 7.60E-14 | 0.1612813936 |